IDYA — Ideaya Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.40bn
- $2.70bn
- $23.39m
- 43
- 14
- 66
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -42 | -34.5 | -49.8 | -58.7 | -113 |
Depreciation | |||||
Non-Cash Items | 1.7 | 4.17 | 10.1 | 10.9 | 6.94 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.284 | 84.4 | -17.8 | -41.6 | -11.7 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -39.3 | 55.5 | -55.8 | -87.2 | -115 |
Capital Expenditures | -1.35 | -0.493 | -2.64 | -3.44 | -2.37 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.62 | -146 | -67 | -30 | -156 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 2.27 | -146 | -69.7 | -33.4 | -158 |
Financing Cash Flow Items | 0 | 20 | 0 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 50.6 | 129 | 145 | 97.2 | 363 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 13.6 | 38 | 20 | -23.4 | 89 |